A number of tightly regulated proteolytic enzyme systems, including the plasminogen activation cascade and matrix metalloproteases, play integral roles in the remodelling of extracellular matrices during pregnancy and parturition. This study assessed these labour-associated changes in protease activity in human gestational tissues. Amnion, choriodecidua and placenta collected from women before (at caesarean section, not in labour), during (at caesarean section, in labour) and after (spontaneous-onset labour, normal vaginal delivery) labour were examined on gelatin-substrate SDS-PAGE zymography. All tissues displayed major 55 kDa plasminogen-dependent activity that was abolished by the serine protease inhibitors (10 mmol phenylmethyl\x=req-\ sulphonylfluoride l \ m= -\ 1 , 100 mmol epsilon aminocaproic acid l \ m= -\ 1 , 1 mmol Glu-Gly-Arg chloromethylketone l \ m=-\ 1) . The enzymic activity was identified as urokinase plasminogen activator on the basis of its co-migration with reference standard and western blot analysis, and did not vary with labour status. An additional protease with an apparent molecular mass of approximately 90 kDa was detected in all tissues. Densitometric measurement of these tissues showed a significant (P < 0.05) increase in this enzyme activity with labour onset. Heavy metal chelators (1 mmol 1,10 phenanthroline l \ m=-\ 1 and 10 mmol EDTA l \ m=-\ 1) selectively blocked the 90 kDa activity, consistent with the proposal that it is a metalloprotease. Co-migration with reference standard and western blot analysis confirmed the identity of this protease as the matrix metalloprotease 9 (MMP\x=req-\ 9). Immunoreactive MMP-9 protein was also significantly (P < 0.05) increased during and after labour compared with before labour in all tissues examined. It is proposed that the upregulated expression of MMP-9 is involved in fetal membrane rupture and placental separation during and after labour onset, respectively. In conclusion, the regulated repertoire of protease activities expressed by human gestational tissues implies an important role for matrix-degrading enzymes during human parturition.
Introduction
Processes that involve extensive extracellular matrix remodelling are intrinsic to successful parturition. Examples of such processes include cervical ripening before delivery, fetal membrane rupture and placental separation from maternal tissues (Rajabi et ah, 1988; Jeffrey, 1991; Granstrom et ah, 1992; Vadillo-Ortega et ah, 1995) . These labourassociated changes depend on the concerted actions of several proteolytic enzyme systems, one of which is the plasminogen activation cascade. This system converts the abundant circulating pro-enzyme plasminogen to the active serine protease plasmin that is capable of degrading most extracellular matrix proteins either directly or indirectly via the activation of latent collagenases (Emonard and Grimaud, 1990 ; Conese and Blasi, 1995; Ries and Petrides, 1995) . The generation of plasmin is dependent upon the availability and activity of urokinase plasminogen activator (uPA) (Vassalli et ah, 1991; Plow et ah, 1995) .
Another important class of mediators of tissue remodelling that has been investigated in human pregnancy and parturition includes the matrix metalloproteases, particularly matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) (Shimonovitz et ah, 1994; BryantGreenwood and Yamamoto, 1995; Vadillo-Ortega et ah, 1995 (Emonard and Grimaud, 1990; Woessner, 1991;  Ries and (Granstrom et ah, 1992) . In addition, comparative evaluation studies of biomechanical properties of human fetal membranes obtained before and after delivery demonstrate a decrease in total collagen content in the amnion as the rupture site is approached (Ibrahim et ah, 1983 67.4 ±12.2, 80.8 ±12.9), choriodecidua (27.7 ± 13.0, 63.6 ± 12.2,86.9 ± 11.7) and amnion (7.1 ± 1.4,65.9 ± 11.9,94.8 ± 11.9)
showed a significant (P < 0.05) increase in this activity that corresponded to labour onset (Fig. 2) .
Inhibition ofproteolytic activity in gestational tissue
Incubation of zymograms in the presence of 1 mmol
Glu-Gly-Arg chloromethylketone l"1, which inhibits uPA specifically, resulted in complete loss of the 55 kDa lysis band (Fig. 3a) . Similar results were obtained with serine protease inhibitors such as 10 mmol PMSF 1_1 and 100 mmol epsilonaminocaproic acid L1 (data not shown). The 90 kDa proteolytic band observed in human gestational tissues was completely inhibited when gels were incubated in the presence of the heavy metal chelators 1 mmol 1,10 phenanthroline L1 and 10 mmol EDTA l"1 (Fig. 3b) , consistent with the proposal that it is a matrix metalloprotease. On the basis of molecular mass and selective inhibition, the lysis band was identified as MMP-9.
Western blot analysis ofgestational tissue proteins
Western blot analysis of amnion, choriodecidual and placental extracts using either a polyclonal antibody raised against human uPA or a monoclonal antibody against human MMP-9 is shown (Fig. 4) Immunoreactive MMP-9 in human gestational tissues
The immunoreactive content of MMP-9 in human term gestational tissues before, during and after spontaneousonset labour was measured by ELISA. A statistically significant (P < 0.05) increase in total immunoreactive MMP-9 protein was observed in placenta, choriodecidua and amnion tissue during and after labour when compared with the before labour group of patients (Fig. 5) . Immunoreactive MMP-9 protein was not significantly different between the groups of patients tested during and after labour (P > 0.05).
Discussion
In this study, it is demonstrated by gelatin-zymography that uPA and MMP-9 proteolytic activity is present in human amnion, choriodecidua and placental extracts. MMP-9 activity increased significantly in these tissues during and after spontaneous-onset labour at term. In contrast, no labourassociated changes were detected in uPA activity. These data are consistent with reports that describe the induction of MMP-9 activity in both human and rat amniochorionic membranes at term (Lei et Dano, 1991; Blasi, 1993; Schmitt et ah, 1995 (Tsatas et ah, 1997) . The ability of plasminogen to bind to human amniochorionic membranes (Burgos et ah, 1982; Jenkins et ah, 1983) and the presence of immunoreactive plasminogen in these tissues (Watanabe et ah, 1993) 
